Michael J. LaBarre
2009
In 2009, Michael J. LaBarre earned a total compensation of $361.6K as Vice President, Product Development at Halozyme Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $63,358 |
|---|---|
| Option Awards | $49,486 |
| Salary | $241,365 |
| Other | $7,386 |
| Total | $361,595 |
LaBarre received $241.4K in salary, accounting for 67% of the total pay in 2009.
LaBarre also received $63.4K in non-equity incentive plan, $49.5K in option awards and $7.4K in other compensation.
Rankings
In 2009, Michael J. LaBarre's compensation ranked 7,855th out of 9,885 executives tracked by ExecPay. In other words, LaBarre earned more than 20.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,855 out of 9,885 | 21st |
Division Manufacturing | 2,935 out of 3,690 | 21st |
Major group Chemicals And Allied Products | 672 out of 871 | 23rd |
Industry group Drugs | 482 out of 643 | 25th |
Industry Biological Products, Except Diagnostic Substances | 90 out of 138 | 35th |
Source: SEC filing on March 24, 2011.
LaBarre's colleagues
We found eight more compensation records of executives who worked with Michael J. LaBarre at Halozyme Therapeutics in 2009.
2009
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2009
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2009
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2009
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2009
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2009
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2009
David Ramsay
Halozyme Therapeutics
Vice President Corporate Development
2009
Robert Little
Halozyme Therapeutics